Position in AMGN
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$6,122,541
+$779,533 QoQ
Shares Held
17,401
+6.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026EXENCIAL WEALTH ADVISORS, LLC holds $76,718,350 across 13 Drug Manufacturers - General names. AMGN ranks #5 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
108,594 | $16,587,733 | |
| 2 | LLY |
ELI LILLY & Co
|
17,141 | $15,765,777 | |
| 3 | JNJ |
Johnson & Johnson
|
41,920 | $10,246,924 | |
| 4 | ABBV |
AbbVie Inc.
|
41,150 | $8,949,713 | |
| 5 | AMGN |
Amgen Inc
This page
|
17,401 | $6,122,541 | |
| 6 | AZN |
Astrazeneca PLC
|
20,162 | $3,976,349 | |
| 7 | SNY |
Sanofi
|
81,382 | $3,920,984 | |
| 8 | GSK |
GSK plc
|
55,198 | $3,046,377 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,122,541 | 17,401 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $5,343,008 | 16,324 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $4,644,447 | 16,458 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $4,373,824 | 15,665 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $5,181,076 | 16,630 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $4,509,332 | 17,301 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $5,857,133 | 18,178 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $5,885,933 | 18,838 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $5,669,340 | 19,940 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $5,667,081 | 19,676 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $5,054,569 | 18,807 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,261,895 | 19,196 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,342,555 | 17,963 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $4,606,968 | 17,541 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,522,325 | 15,627 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $3,664,584 | 15,062 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,633,103 | 15,024 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,257,565 | 14,480 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,957,748 | 13,909 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $2,954,493 | 12,121 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,555,992 | 14,292 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,745,474 | 11,941 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $5,923,198 | 23,305 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,800,129 | 11,872 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $544,938 | 2,688 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||